AaiPharma CEO Retires
This article was originally published in The Pink Sheet Daily
Executive Summary
Former Quintiles executive Ludo Reynders, PhD, will assume the post of aaiPharma CEO following the retirement of the company's founder Frederick Sancilio, aaiPharma announced Sept. 28
You may also be interested in...
AaiPharma CEO Steps Down; “Restructuring Expert” Joins As Operations Exec
Founder Sancilio is taking back the CEO role for at least a year, AaiPharma says. FTI consultant Gregory Rayburn is joining as chief operating officer to handle banking and creditor issues.
Cancer-Genomics Firm Quanticel Debuts With Close Ties To Celgene, And An Exit In Mind
Celgene will get exclusive use of Quanticel's single-cell genomic analysis to tweak its clinical pipeline, and it also has exclusive options to acquire the venture-backed start-up.
One Trial Plus Supportive Evidence Is Enough For Hospital-, Ventilator-Acquired Pneumonia Indication, Panel Says
Anti-Infective Drugs Advisory Committee members viewed one-trial as practical means of gaining efficacy data.